Vycor Medical (VYCO) Net Income towards Common Stockholders (2010 - 2026)
Vycor Medical's (VYCO) quarterly Net Income towards Common Stockholders came in at -$142077.0 in Q1 2026, up 29.23% year-on-year from -$109944.4 in Q1 2025, and down 126.65% on a QoQ basis from -$62686.0 in Q4 2025.
Vycor Medical (VYCO) Net Income towards Common Stockholders (2010 - 2026) Analysis & Trends
Vycor Medical (VYCO) has 17 years of Net Income towards Common Stockholders data on file, last reported at -$142077.0 in Q1 2026.
- On a quarterly basis, Net Income towards Common Stockholders rose 29.23% year-over-year to -$142077.0 in Q1 2026; TTM through Mar 2026 was -$338125.0, a 23.07% increase from a year earlier, with the FY2025 full-year figure at -$396796.0, up 8.06% from the prior year.
- Net Income towards Common Stockholders for Q1 2026 stood at -$142077.0, down from -$62686.0 in the prior quarter.
- Over the last five years, Net Income towards Common Stockholders for VYCO reached as high as $68406.0 in Q2 2023 and fell as low as -$276992.0 in Q3 2022.
- Historically, Net Income towards Common Stockholders has averaged -$123164.2 across 5 years, with a median of -$142077.0 in 2026.
- Across the five-year window, Net Income towards Common Stockholders slumped 956.22% in 2022 and jumped 337.97% in 2025, its largest moves.
- Year by year, Net Income towards Common Stockholders stood at -$116548.0 in 2022, then climbed by 20.16% to -$93055.0 in 2023, then jumped by 92.76% to -$6737.0 in 2024, then sank by 830.47% to -$62686.0 in 2025, then sank by 126.65% to -$142077.0 in 2026.
- Per Business Quant data, the three most recent Net Income towards Common Stockholders figures were -$142077.0 in Q1 2026, -$62686.0 in Q4 2025, and -$157249.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 199.50 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 411.00 Mn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 176.78 Mn |
| 10 | Vycor Medical | 2.34 Mn | 2.16 Mn | 375,153.00 | -142,077.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -142,077.00 |
| Dec 31, 2025 | -62,686.00 |
| Sep 30, 2025 | -157,249.00 |
| Jun 30, 2025 | 23,887.00 |
| Mar 31, 2025 | -200,748.00 |
| Dec 31, 2024 | -6,737.00 |
| Sep 30, 2024 | -222,002.00 |
| Jun 30, 2024 | -10,038.00 |
| Mar 31, 2024 | -192,793.00 |
| Dec 31, 2023 | -93,055.00 |
| Sep 30, 2023 | -214,089.00 |
| Jun 30, 2023 | 68,406.00 |
| Mar 31, 2023 | -155,323.00 |
| Dec 31, 2022 | -116,548.00 |
| Sep 30, 2022 | -276,992.00 |
| Jun 30, 2022 | -99,010.00 |
| Mar 31, 2022 | -236,737.00 |
| Dec 31, 2021 | -187,062.00 |
| Sep 30, 2021 | -158,492.00 |
| Jun 30, 2021 | -9,374.00 |